PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
SEER vs. GANX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between SEER and GANX is 0.22, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

SEER vs. GANX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Seer, Inc. (SEER) and Gain Therapeutics, Inc. (GANX). The values are adjusted to include any dividend payments, if applicable.

0.00%50.00%100.00%AugustSeptemberOctoberNovemberDecember2025
24.54%
68.52%
SEER
GANX

Key characteristics

Sharpe Ratio

SEER:

0.56

GANX:

-0.38

Sortino Ratio

SEER:

1.26

GANX:

0.06

Omega Ratio

SEER:

1.14

GANX:

1.01

Calmar Ratio

SEER:

0.30

GANX:

-0.41

Martin Ratio

SEER:

1.94

GANX:

-0.69

Ulcer Index

SEER:

15.30%

GANX:

56.06%

Daily Std Dev

SEER:

52.55%

GANX:

102.52%

Max Drawdown

SEER:

-98.25%

GANX:

-94.08%

Current Drawdown

SEER:

-97.24%

GANX:

-86.46%

Fundamentals

Market Cap

SEER:

$136.80M

GANX:

$56.76M

EPS

SEER:

-$1.32

GANX:

-$1.07

Total Revenue (TTM)

SEER:

$10.08M

GANX:

$0.00

Gross Profit (TTM)

SEER:

$1.94M

GANX:

-$41.12K

EBITDA (TTM)

SEER:

-$72.05M

GANX:

-$16.97M

Returns By Period

In the year-to-date period, SEER achieves a 0.43% return, which is significantly higher than GANX's -0.93% return.


SEER

YTD

0.43%

1M

-6.45%

6M

24.73%

1Y

32.57%

5Y*

N/A

10Y*

N/A

GANX

YTD

-0.93%

1M

28.92%

6M

68.50%

1Y

-41.37%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

SEER vs. GANX — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SEER
The Risk-Adjusted Performance Rank of SEER is 6666
Overall Rank
The Sharpe Ratio Rank of SEER is 6868
Sharpe Ratio Rank
The Sortino Ratio Rank of SEER is 6868
Sortino Ratio Rank
The Omega Ratio Rank of SEER is 6363
Omega Ratio Rank
The Calmar Ratio Rank of SEER is 6262
Calmar Ratio Rank
The Martin Ratio Rank of SEER is 6868
Martin Ratio Rank

GANX
The Risk-Adjusted Performance Rank of GANX is 3131
Overall Rank
The Sharpe Ratio Rank of GANX is 2828
Sharpe Ratio Rank
The Sortino Ratio Rank of GANX is 3636
Sortino Ratio Rank
The Omega Ratio Rank of GANX is 3636
Omega Ratio Rank
The Calmar Ratio Rank of GANX is 2323
Calmar Ratio Rank
The Martin Ratio Rank of GANX is 3434
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

SEER vs. GANX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Seer, Inc. (SEER) and Gain Therapeutics, Inc. (GANX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for SEER, currently valued at 0.56, compared to the broader market-2.000.002.000.56-0.38
The chart of Sortino ratio for SEER, currently valued at 1.26, compared to the broader market-4.00-2.000.002.004.001.260.06
The chart of Omega ratio for SEER, currently valued at 1.14, compared to the broader market0.501.001.502.001.141.01
The chart of Calmar ratio for SEER, currently valued at 0.30, compared to the broader market0.002.004.006.000.30-0.41
The chart of Martin ratio for SEER, currently valued at 1.94, compared to the broader market-30.00-20.00-10.000.0010.0020.001.94-0.69
SEER
GANX

The current SEER Sharpe Ratio is 0.56, which is higher than the GANX Sharpe Ratio of -0.38. The chart below compares the historical Sharpe Ratios of SEER and GANX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.00AugustSeptemberOctoberNovemberDecember2025
0.56
-0.38
SEER
GANX

Dividends

SEER vs. GANX - Dividend Comparison

Neither SEER nor GANX has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

SEER vs. GANX - Drawdown Comparison

The maximum SEER drawdown since its inception was -98.25%, roughly equal to the maximum GANX drawdown of -94.08%. Use the drawdown chart below to compare losses from any high point for SEER and GANX. For additional features, visit the drawdowns tool.


-95.00%-90.00%-85.00%-80.00%AugustSeptemberOctoberNovemberDecember2025
-95.92%
-86.46%
SEER
GANX

Volatility

SEER vs. GANX - Volatility Comparison

The current volatility for Seer, Inc. (SEER) is 11.63%, while Gain Therapeutics, Inc. (GANX) has a volatility of 30.46%. This indicates that SEER experiences smaller price fluctuations and is considered to be less risky than GANX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%20.00%30.00%40.00%AugustSeptemberOctoberNovemberDecember2025
11.63%
30.46%
SEER
GANX

Financials

SEER vs. GANX - Financials Comparison

This section allows you to compare key financial metrics between Seer, Inc. and Gain Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab